SMSPHARMANSESMS Pharmaceuticals Limited· PharmaceuticalsMinimalNeutral
Announced Tue, 10 Feb · 18:35 IST

Monitoring Agency Report for 31st December, 2025

SMSPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

SMS Pharmaceuticals has filed a Monitoring Agency Report covering the period ending 31st December 2025. This is a SEBI-mandated compliance disclosure required when a company has raised funds through a public, rights, or preferential issue, where an independent agency tracks how the proceeds are being deployed. The report gives shareholders visibility into whether the company is using the raised money as originally promised in the issue documents. Investors should compare the report details against the stated object of the fundraising to spot any deviations or delays. Without the detailed numbers here, shareholders are advised to pull the full PDF for line-item fund utilization status.

Likely market impact

Routine compliance filing with no direct price action, but any material deviation from the originally disclosed purpose of fund use could be a red flag affecting investor confidence.